Drug Topics

DECEMBER 28, 2022

Take a look back at our most popular Total Pharmacy coverage for 2022.

247

247

Fierce Healthcare

DECEMBER 28, 2022

XBB COVID variant presents a unique threat: study. fdiamond. Wed, 12/28/2022 - 11:11.

145

145

Drug Topics

DECEMBER 28, 2022

Take a look back at our most popular pain management coverage for 2022.

247

247

Pharmacy Times

DECEMBER 28, 2022

Products range from acne treatment to cough relief.

121

121

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

DECEMBER 28, 2022

ACA exchange enrollment continues at record pace, nears 11.5M through mid-December. pminemyer. Wed, 12/28/2022 - 11:48.

119

119

PharmExec

DECEMBER 28, 2022

Top industry experts weigh in on what the new year holds for the pharma industry.

119

119

The Thyroid Pharmacist

DECEMBER 28, 2022

As far back as I can remember, I’ve wanted to help people with their health. I grew up watching my mom work as a medical doctor, and always admired her. In elementary school, I was introduced to the scientific method and thought: “This is it! This is what I’m going to do when I grow up!”. I enrolled in a four-year PharmD program (Doctor of Pharmacy) and became a pharmacist with the goal that one day, I would be able to discover new treatments for people who were suffering.

Immunization 111

Immunization Labelling FDA 111

Drug Store News

DECEMBER 28, 2022

Lynne Fruth, president and chairman of Fruth Pharmacy, shares her insights on the current state of the pharmacy business.

106

106

STAT

DECEMBER 28, 2022

When Eric Xu fell sick and tested positive with Covid this month, he took pills of his own invention.  Paxlovid, the primary oral antiviral available in the U.S., is in short supply in China. But Xu, a prominent biochemist at the Chinese Academy of Sciences, had helped devise his own in 2021 and, as the drug’s inventor, could legally take it even as it went through clinical trials.

105

105

pharmaphorum

DECEMBER 28, 2022

Gilead Sciences must like what it has seen in a two-year-old partnership with Jounce Therapeutics for a CCR8-targeting cancer immunotherapy – it has just agreed to take full ownership of the programme. The drug in question – codenamed GS-1811 (formerly JTX-1811) – is an antibody drug designed to selectively deplete T regulatory cells in the tumour microenvironment that has been taken into phase 1 clinical testing as a monotherapy and in combination with PD-1 inhibitor zimberelimab for solid tumo

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

DECEMBER 28, 2022

The United States will require all travelers from China to show a negative Covid-19 test before boarding flights to the U.S., federal health officials announced Wednesday, citing concerns about a surge of Covid infections in China and a lack of transparency from Chinese government officials about how widespread that country’s outbreak is.  “We know these measures will not eliminate all risk or completely prevent people who are infected from entering the United States,”

98

98

pharmaphorum

DECEMBER 28, 2022

Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process. Now, those field sales experts need to sell virtually – which can be increasingly difficult when healthcare professionals have a packed schedule and limited time away from patients and the practice.

Communication 98

Communication Hospitals Patient Care 98

STAT

DECEMBER 28, 2022

For medical devices in the Breakthrough Devices Program, 2022 has been a breakout year. The Food and Drug Administration is on track to top its previous records, offering expedited regulatory consideration — and if medical device companies have their way, a streamlined path to insurance coverage — to dozens of novel tools.

Insurance Coverage 98

Insurance Coverage Insurance 98

The Checkup by Singlecare

DECEMBER 28, 2022

Upset stomachs are one of the most unpleasant symptoms one can experience. Humans will do almost anything to avoid the feeling of nausea, heartburn, or “sour stomach.” A pet with an upset tummy is also a sad sight to behold. As a pet owner, you want to avoid having your pet suffer at all, and also want to keep them from vomiting or having diarrhea—which can be dangerous if uncontrolled, not to mention messy and potentially harmful to your carpets. .

Dosage 96

Dosage Labelling Hospitals 96

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

DECEMBER 28, 2022

The U.S. health system has been evolving over the past decade to focus on the quality and value of care. Until recently, though, value-based payment models have not explicitly addressed longstanding racial and ethnic inequities in care. This month, Blue Cross Blue Shield of Massachusetts, the not-for-profit health plan I lead, introduced a value-based payment model that will reward clinicians for closing equity gaps, starting with areas including colorectal cancer screening, blood pressure contr

Insurance 98

Insurance 98

Pharmacy Times

DECEMBER 28, 2022

Can you relate?

94

94

STAT

DECEMBER 28, 2022

Reflecting back on our favorite photographs from 2022, we are struck by how many portraits were in our selection. This year, more than others, the strength of individuals was at the center of our visual journalism. Our photographers have pictured medical students fighting for racial justice; harm reduction workers and crisis line volunteers; and patients, families, and researchers fighting to find life-saving cures.

Documentation 98

Documentation 98

pharmaphorum

DECEMBER 28, 2022

Biogen’s efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug candidate it licensed from China’s InnoCare last year for $125 million upfront. The US regulator has placed oral BTK inhibitor orelabrutinib on partial clinical hold, meaning new patients cannot be enrolled into clinical trials and patients treated with the drug for 70 days or less must discontinue treatment.

FDA 75

FDA 75

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Commerce

DECEMBER 28, 2022

Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton.

72

72

Fierce Pharma

DECEMBER 28, 2022

UCB's bimekizumab finally back on the FDA's review list after May rejection. zbecker. Wed, 12/28/2022 - 11:17.

FDA 59

FDA 59

Fuld

DECEMBER 28, 2022

No one can predict the future, but you can build a strategic plan for it. To align resources, navigate a competitive marketplace, and make mission-critical business decisions, your organization must effectively identify, anticipate and address the external forces and create and implement a clear plan for the future by using a modern-age strategic planning framework.

52

52

BuzzRx

DECEMBER 28, 2022

Cold weather in the winter brings with it more than just a sharp drop in temperature. When you crank up the heating to stay warm, you end up with overly dry air. Dry air can not only lead to health issues like dry skin , scratchy throats, and nosebleeds but also cause damage to your home and result in high utility bills. A humidifier can add moisture in the air and help to maintain humidity levels in your home.

52

52

Drug Store News

DECEMBER 28, 2022

A New Jersey judge has ordered Bausch Health to provide advance notice of intent to spin in order to allow injunction challenge.

52

52

Med Ed 101

DECEMBER 28, 2022

The 2023 BCACP Exam looks to have some consistency with the previous year. The last major change to the content outline was in 2020. I would anticipate that we may see some changes in 2024 or 2025 as these exam outlines tend to get reviewed and updated every 3-5 years. I think this is generally […]. The post 2023 BCACP Exam – What You Need To Know appeared first on Med Ed 101.

52

52

Drug Store News

DECEMBER 28, 2022

Generic Carnitor is used for the treatment of primary systemic carnitine deficiency.

52

52

Pharmaceutical Technology

DECEMBER 28, 2022

Gilead Sciences and Jounce Therapeutics have amended their current license agreement for first-in-class immunotherapy, GS-1811 (formerly JTX-1811). The initial license agreement was signed in 2020. The amended agreement will allow Gilead Sciences to acquire all the remaining rights for GS-1811 from Jounce Therapeutics. Certain operational obligations of the companies that are related to GS-1811 have also been terminated as part of the transaction.

Immunization 52

Immunization 52

Drug Store News

DECEMBER 28, 2022

Which retail pharmacies, pharma companies and wholesalers are among those companies that made Newsweek’s list of American's Most Responsible Companies?

52

52

The Checkup by Singlecare

DECEMBER 28, 2022

Maybe you’re one of the 50-70 million individuals in the United States with a sleep disorder. Maybe you just have difficulty falling asleep from time to time. Either way, you may have turned to melatonin to help you catch more zzz’s before trying a prescription medication or over-the-counter sleep aid. Melatonin is a naturally occurring hormone that is produced by a tiny gland in the brain (called the pineal gland) that normally regulates the body’s sleep-wake cycle, or circadian rhythm, accordi

Dosage 98

Dosage Hospitals Chemotherapy Labelling 98

STAT

DECEMBER 28, 2022

It was not that long ago that the medical community had a small arsenal of new drugs to prevent and treat COVID-19 in people most susceptible to severe disease. But the arrival of new variants, as well as the loss of two treatments for immunocompromised people, has amped up the urgency to develop a stronger generation of medicines. Some biotech companies are looking to rebuild and expand the war chest, including British pharmaceutical giant AstraZeneca and several smaller Massachusetts firms.

98

98

pharmaphorum

DECEMBER 28, 2022

After years of preparation, the US Congress passed the Pre-approval Information Exchange (PIE) Act just ahead of the Christmas break, legislation that will allow medical payers and the FDA to review new treatments concurrently. The act – which still needs to be signed into law by President Joe Biden – could shave months or even years off the time it takes for novel treatments to be available to patients, according to its sponsors.

Insurance 52

Insurance FDA 52

STAT

DECEMBER 28, 2022

The U.S. is experiencing its deadliest drug crisis ever, and there’s no end in sight. And even as nearly 108,000 Americans die of drug overdose every 12 months, the federal government hasn’t changed much about its approach to drug use and addiction.  With Republicans and Democrats each set to control one chamber of Congress, most advocates aren’t expecting Capitol Hill to suddenly step in.

98

98